Proton Pump Inhibitors Intake and Iron and Vitamin B12 Status: A Prospective Comparative Study with a Follow up of 12 Months
Authors:
Open Access
- 12 March 2018
- journal article
- Published by Scientific Foundation Spiroski (publications) in Open Access Macedonian Journal of Medical Sciences
- Vol. 6 (3) , 442-446
Abstract
BACKGROUND: Proton pump inhibitors (PPIs) represent the most widely prescribed antisecretory agents, but their prolonged use, may influence iron and vitamin B12 status, which could have important implications for clinical practice.AIM: We undertook this study aiming to investigate the association between PPIs use for 12 months and potential changes in iron and vitamin B12 status, as well as whether this potential association varies among four specific PPI drugs used in the study.METHODS: A total of 250 adult subjects were recruited into this study, of which 200 subjects were PPIs users while 50 subjects belonged to the control group. Serum iron, ferritin, vitamin B12, and homocysteine (Hcy) levels were measured before the start of the study and after 12 months. Mann - Whitney U test and Kruskal - Wallis test was used to compare the baseline characteristics of the study groups, while Wilcoxon test was used to analyse post - pre differences.RESULTS: Statistical analysis showed significant changes within PPIs group and specific PPIs subgroups between the two-time points in serum ferritin and vitamin B12 levels, respectively, while no significant changes in serum iron and homocysteine levels were shown. However, subsequent diagnosis of hypoferremia and hypovitaminosis B12 in the whole study sample at 12 months was established in only 3.8% and 2.9% of the subjects, respectively.CONCLUSION: PPIs use for 12 months did not result in clinically significant iron and/or vitamin B12 deficiency; thus, these findings argue routine screening under normal circumstances, although monitoring in elderly and malnourished may be of precious value.Keywords
This publication has 28 references indexed in Scilit:
- Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in miceBlood, 2011
- Adverse Effects of Long-Term Proton Pump Inhibitor TherapyDigestive Diseases and Sciences, 2011
- Association Between Proton Pump Inhibitor Use and Anemia: A Retrospective Cohort StudyDigestive Diseases and Sciences, 2011
- Vitamin B12 Deficiency is Linked with Long-Term Use of Proton Pump Inhibitors in Institutionalized Older Adults: Could a Cyanocobalamin Nasal Spray be Beneficial?Journal of Nutrition For the Elderly, 2010
- Do Acid-Lowering Agents Affect Vitamin B12 Status in Older Adults?Journal of the American Medical Directors Association, 2008
- Long‐term use of proton pump inhibitors and vitamin B12 status in elderly individualsAlimentary Pharmacology & Therapeutics, 2008
- Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosisGut, 2007
- Effect of Omeprazole on Oral Iron Replacement in Patients with Iron Deficiency AnemiaSouthern Medical Journal, 2004
- Effect of short‐ and long‐term treatment with omeprazole on the absorption and serum levels of cobalaminAlimentary Pharmacology & Therapeutics, 1996
- Review article: metabolic consequences of long‐term inhibition of acid secretion by omeprazoleAlimentary Pharmacology & Therapeutics, 1992